-
- Description: Large Scale Biology Corp. develops therapeutic products using proprietary technologies and expertise. The product categories in which it has made the most progress using biomanufacturing technology are vaccines for the treatment of cancer and the treatment and prevention of infectious diseases, including disease agents of potential concern in biological warfare, and the low-cost production of complex proteins for therapeutic product applications. Some of the products on which the Company is working include a therapeutic vaccine for treatment of non-Hodgkin's lymphoma (NHL), the NHL vaccine; a proprietary form of human alpha-galactosidase A for the treatment of Fabry disease, a lysosomal storage disorder; a generic form of bovine aprotinin, a protease inhibitor used in cardiac surgery, and a series of prototype vaccines and prototype products for the expansion of bone marrow and cord blood stem cells. Large Scale Biology Corporation develops, manufactures and commercialize plant made pharmaceutical proteins and vaccines. General Information Year established 1994
- More Products No Keyword available...
- About Owner No Owner Type Present...
-
